A phaseIIIrandomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – theTEAM‐ET2·0 trialHeinz Gisslinger,Veronika Buxhofer‐Ausch,Juri Hodisch,Atanas Radinoff,Elena Karyagina,Slawomira Kyrcz‐Krzemień,Kudrat Abdulkadyrov, Rolandas Gerbutavicius, Anait Melikyan,Sonja Burgstaller, Marek Hus,Janusz Kłoczko,Vera Yablokova,Nikolay Tzvetkov,Malgorzata Całbecka, Tatyana Shneyder,Krzysztof Warzocha,Mindaugas Jurgutis,Kamil Kaplanov,Bernd Jilma,Christian Schoergenhofer,Christoph KladeBritish Journal of Haematology（2019）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
